The ongoing clinical advancement programme is evaluating regular oral and bi-regular/quarterly intravenous dosage regimens in females with postmenopausal osteoporosis. Once daily Bonviva is definitely indicated for the procedure and avoidance of osteoporosis in postmenopausal ladies by reduced amount of elevated bone turnover, raising bone mineral density and reduced amount of the incidence of vertebral fractures.. Bonviva, to take care of osteoporosis, submitted for advertising authorisation in Europe Roche and GlaxoSmithKline announced today the submission of a Marketing Authorisation Program to the European authorities for a novel, once-regular monthly oral formulation of their new bisphosphonate, Bonviva , for the treating postmenopausal osteoporosis.We look forward to dealing with the IJS over the arriving years. ASiT Associates will be offered usage of the online journal at a heavily discounted rate as an advantage of membership. ASiT associates will access the IJS through a personalised site with extra features and content. Members will be encouraged to submit their function to the peer-examined journal and benefit from the wide range of Elsevier author solutions.
Aristolochic acid leads to kidney failure, upper urinary tract cancer Aristolochic acid, a component of a plant found in herbal treatments since ancient times and still used in specific herbal medicines worldwide, leads to kidney failure and top urinary system cancer in individuals exposed to the toxin.